MeiraGTx Holdings (MGTX) Equity Average (2018 - 2025)
MeiraGTx Holdings posted quarterly Equity Average of -$23.2 million for Q4 2025, down 128.34% year-on-year from $81.8 million in Q4 2024, and down 23.28% on a QoQ basis from -$18.8 million in Q3 2025.
MeiraGTx Holdings (MGTX) has 8 years of Equity Average data on file, last reported at -$23.2 million in Q4 2025.
- For the quarter ending Q4 2025, Equity Average fell 128.34% year-over-year to -$23.2 million; the trailing twelve-month figure through Dec 2025 stood at -$23.2 million (down 128.34% YoY), and the FY2025 full-year result was $31.0 million, down 69.89% from the prior year.
- Equity Average for Q4 2025 stood at -$23.2 million, down from -$18.8 million in the prior quarter.
- Across five years, Equity Average topped out at $229.7 million in Q1 2021 and bottomed at -$23.2 million in Q4 2025.
- The 5-year median for Equity Average is $111.4 million (2023), against an average of $113.2 million.
- The widest annual swing landed in 2024, when Equity Average increased 24.98%; it then slumped 128.34% in 2025.
- A 5-year view of Equity Average shows it stood at $186.6 million in 2021, then slumped by 35.59% to $120.2 million in 2022, then retreated by 4.3% to $115.0 million in 2023, then slipped by 28.91% to $81.8 million in 2024, then slumped by 128.34% to -$23.2 million in 2025.
- The last three Equity Average figures came in at -$23.2 million (Q4 2025), -$18.8 million (Q3 2025), and $18.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 3.76 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 21.35 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 19.01 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 31.34 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 932.28 Mn |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | -23.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -23.18 Mn |
| Sep 30, 2025 | -18.80 Mn |
| Jun 30, 2025 | 18.03 Mn |
| Mar 31, 2025 | 50.46 Mn |
| Dec 31, 2024 | 81.78 Mn |
| Sep 30, 2024 | 87.89 Mn |
| Jun 30, 2024 | 100.89 Mn |
| Mar 31, 2024 | 129.96 Mn |
| Dec 31, 2023 | 115.03 Mn |
| Sep 30, 2023 | 107.71 Mn |
| Jun 30, 2023 | 106.87 Mn |
| Mar 31, 2023 | 103.98 Mn |
| Dec 31, 2022 | 120.20 Mn |
| Sep 30, 2022 | 132.32 Mn |
| Jun 30, 2022 | 151.63 Mn |
| Mar 31, 2022 | 173.34 Mn |
| Dec 31, 2021 | 186.62 Mn |
| Sep 30, 2021 | 196.78 Mn |
| Jun 30, 2021 | 213.26 Mn |
| Mar 31, 2021 | 229.68 Mn |
| Dec 31, 2020 | 208.82 Mn |
| Sep 30, 2020 | 175.93 Mn |
| Jun 30, 2020 | 178.85 Mn |
| Mar 31, 2020 | 187.86 Mn |
| Dec 31, 2019 | 192.85 Mn |
| Sep 30, 2019 | 162.23 Mn |
| Jun 30, 2019 | 136.99 Mn |
| Mar 31, 2019 | 112.74 Mn |
| Dec 31, 2018 | 88.70 Mn |
| Sep 30, 2018 | 102.41 Mn |
| Jun 30, 2018 | 23.78 Mn |
| Mar 31, 2018 | -54.14 Mn |